Skip to main content

AI Drug Discovery Startups: Atomwise Focuses On AI-Based Small Molecule Discovery

Atomwise was founded in 2012 with the intention of finding cures for common and orphan diseases that are too expensive and time-intensive for pharma companies to find a cure for.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.